Ryght AI, the platform redefining clinical trial execution with its AI Site Twin technology, is set to take center stage at HLTH 2025 in Las Vegas. From October 19–22, healthcare leaders, sponsors, and CROs can see live demonstrations of the platform at the Microsoft Booth (#3860, Level 2, AI Zone).
The conference, which gathers over 12,000 executives and innovators, offers a premier stage for Ryght to highlight how generative AI is transforming site selection, feasibility, and study operations. Ryght’s integration into Microsoft Azure Marketplace underscores the momentum of AI-driven clinical research solutions, allowing sponsors and CROs to leverage existing cloud investments while adopting cutting-edge AI.
“HLTH represents a unique opportunity to connect with healthcare innovators actively seeking solutions to accelerate clinical trial timelines,” said Simon Arkell, CEO and Co-Founder of Ryght AI. “Our AI Site Twin technology is helping organizations get treatments to patients faster while reducing costs and operational complexity.”
AI Site Twins: Smarter Clinical Trials
Ryght’s platform creates dynamic digital twins of every clinical research site worldwide, capturing operational characteristics, past trial performance, principal investigator expertise, and regulatory history. These AI Site Twins automate previously manual workflows, cutting trial start-up timelines by up to 60%. Faster site identification and feasibility translate directly into quicker program launches and millions of dollars in extended market exclusivity.
At HLTH, Ryght will demonstrate how its AI-powered platform improves study execution by:
- Reducing Delays: Accelerated site start-up with automated prequalification workflows
- Enhancing Accuracy: Improved enrollment forecasting and budget modeling reduce financial risk
- Optimizing Costs: Minimized mid-trial delays, amendments, and rescue strategies through proactive planning
- Boosting Efficiency: Streamlined site engagement with high-fit, high-capacity research partners
The live demos offer attendees hands-on insight into how AI Site Twins can transform clinical trial operations, from smarter site selection to more accurate budgeting and streamlined communication.
Strategic Microsoft Partnership
Ryght’s availability on Microsoft Azure Marketplace allows organizations to integrate AI capabilities with existing cloud commitments seamlessly. The SOC Type 2-compliant platform also supports real-time communication among sponsors, CROs, and research sites, further enhancing trial efficiency.
Power Tomorrow’s Intelligence — Build It with TechEdgeAI
